Institutional investors purchased a net $4.2 million shares of AZN during the quarter ended December 2016 and now own 12.96% of the total shares outstanding. This is a greater percentage than is typical for companies in the Pharmaceuticals: Major industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
T. ROWE PRICE INTERNATIONAL LTD. Bought 6.1 Million shares of AstraZeneca
ACADIAN ASSET MANAGEMENT LLC Bought 1.5 Million shares of AstraZeneca
HENNESSY ADVISORS, INC. (INVESTM... Bought 183.8 Thousand shares of AstraZeneca